Hongbo Jing; Yanhui Yang; Mu He; Yanbo Wang; Yu Zhao; Zhan Li; He Zhang; Nan Jia; Yanmeng Gao; Shengtian Liu; Tao Peng; Miao Jin; Hongbo Jing; Yanhui Yang; Mu He; Yanbo Wang; Yu Zhao; Zhan Li; He Zhang; Nan Jia; Yanmeng Gao; Shengtian Liu; Tao Peng; Miao Jin

doi:10.46234/ccdcw2025.129

[1]

Chhabra P, de Graaf M, Parra GI, Chan MCW, Green K, Martella V, et al. Updated classification of norovirus genogroups and genotypes. J Gen Virol 2019;100(10):1393 − 406. https://doi.org/10.1099/jgv.0.001318.

[2]

Vinjé J. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol 2015;53(2):373 − 81. https://doi.org/10.1128/jcm.01535-14.

[3]

Jin M, Zhou YK, Xie HP, Fu JG, He YQ, Zhang S, et al. Characterization of the new GII. 17 norovirus variant that emerged recently as the predominant strain in China. J Gen Virol 2016;97(10):2620 − 32. https://doi.org/10.1099/jgv.0.000582.

[4]

Kwok K, Niendorf S, Lee N, Hung TN, Chan LY, Jacobsen S, et al. Increased detection of emergent recombinant norovirus GII.P16-GII.2 strains in young adults, Hong Kong, China, 2016-2017. Emerg Infect Dis 2017;23(11):1852-5. http://dx.doi.org/10.3201/eid2311.170561.

[5]

Bidalot M, Théry L, Kaplon J, De Rougemont A, Ambert-Balay K. Emergence of new recombinant noroviruses GII.p16-GII.4 and GII.p16-GII.2, France, winter 2016 to 2017. Euro Surveill 2017;22(15):30508. http://dx.doi.org/10.2807/1560-7917.ES.2017.22.15.30508.

[6]

Gao ZY, Liu BW, Yan HQ, Li WH, Jia L, Tian Y, et al. Norovirus outbreaks in Beijing, China, from 2014 to 2017. J Infect 2019;79(2):159 − 66. https://doi.org/10.1016/j.jinf.2019.05.019.

[7]

Cannon JL, Barclay L, Collins NR, Wikswo ME, Castro CJ, Magana LC, et al. Genetic and epidemiologic trends of norovirus outbreaks in the United States from 2013 to 2016 demonstrated emergence of novel GII. 4 recombinant viruses. J Clin Microbiol 2017;55(7):2208 − 21. https://doi.org/10.1128/JCM.00455-17.

[8]

Jin M, Wu SY, Kong XY, Xie HP, Fu JG, He YQ, et al. Norovirus outbreak surveillance, China, 2016-2018. Emerg Infect Dis 2020;26(3):437 − 45. https://doi.org/10.3201/eid2603.191183.

[9]

Zhu X, He YQ, Wei XY, Kong XY, Zhang Q, Li JX, et al. Molecular epidemiological characteristics of gastroenteritis outbreaks caused by norovirus GII.4 sydney [P31] strains - China, October 2016-December 2020. China CDC Wkly 2021;3(53):1127-32. http://dx.doi.org/10.46234/ccdcw2021.276.

[10]

Steele MK, Wikswo ME, Hall AJ, Koelle K, Handel A, Levy K, et al. Characterizing norovirus transmission from outbreak data, United States. Emerg Infect Dis 2020;26(8):1818 − 25. https://doi.org/10.3201/eid2608.191537.

[11]

Ao YY, Cong X, Jin M, Sun XM, Wei XM, Wang JJ, et al. Genetic analysis of reemerging GII.P16-GII.2 noroviruses in 2016-2017 in China. J Infect Dis 2018;218(1):133-43. http://dx.doi.org/10.1093/infdis/jiy182.

[12]

Mahar JE, Bok K, Green KY, Kirkwood CD. The importance of intergenic recombination in norovirus GII. 3 evolution. J Virol 2013;87(7):3687 − 98. https://doi.org/10.1128/JVI.03056-12.

[13]

Bruggink LD, Moselen JM, Marshall JA. The comparative molecular epidemiology of GII.P7_GII.6 and GII.P7_GII.7 norovirus outbreaks in Victoria, Australia, 2012-2014. Intervirology 2016;59(1):60-5. http://dx.doi.org/10.1159/000448100.

[14]

Rivera-Gutiérrez X, Morán P, Taboada B, Serrano-Vázquez A, Iša P, Rojas-Velázquez L, et al. High prevalence and diversity of caliciviruses in a community setting determined by a metagenomic approach. Microbiol Spectr 2022;10(1):e0185321. https://doi.org/10.1128/spectrum.01853-21.